In the MM stage, the expression of interferon regulatory factor 1 (IRF1) is specifically downregulated, and HLA-E, which plays a key inhibitory role on NK cells, is significantly expressed in malignant melanocytes and fibroblasts. Here, IRF1 is linked to Miyoshi myopathy.